Witek Theodore L Jr

Avg. Two Year Performance

No purchase track record

(2%) Avg. Sale Return

(1%) Compound

	1 Mo	3 Mo	6 Mo	1 Yr	2 Yr
Average Purchase Return	--	--	--	--	--
Purchase Success Rate	--	--	--	--	--
Average Sale Return	(4%)	(8%)	(2%)	(6%)	(2%)
Sale Success Rate	2 of 5	1 of 5	1 of 5	2 of 5	3 of 5

Theravance Inc.

Drugs » Biotechnology

Sr. VP & Chief Scientific Off.:

Holdings: 247.77K shares

Sentiment

Avg. Two Year Performance

No purchase track record

No sale track record

Last Three Months:

0 Net Amount

Buy:	0	--
Sell:	0	--